In line with previous reports [28, 43], transfection of miR-222 precursor into melanoma cells reduced ICAM1 at the post-transcriptional level (Figure 5E) and enhanced the resistance to TIL-mediated killing (Figure 5G), similar to the effect of ADAR1 knockdown. Here, ADAR is linked to melanoma.